We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
+22.74%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$205M
AUM Growth
-$61.3M
Cap. Flow
-$102M
Cap. Flow %
-49.5%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$81.2M
2
CYTK icon
Cytokinetics
CYTK
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 89.76%
2 Miscellaneous 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$108M 52.6%
1,111,111
-1,000,000
-47% -$81.2M
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$76.2M 37.14%
9,166,667
– –
EPZM
3
CALL
DELISTED
Epizyme, Inc
EPZM
$21M 10.24%
2,527,736
+16,259
+0.6% +$137K
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$42K 0.02%
3,700
– –
CYTK icon
5
Cytokinetics
CYTK
$10.8B
– –
-875,656
Closed -$20.4M

Similar funds

PC
Paradoxiom Capital Stamford, Connecticut $154M AUM
LA
LPF Advisors Sarasota, Florida $122M AUM 3.12% 1-Year Est. Return
TP
Thunderbird Partners London, United Kingdom $113M AUM 8.51% 1-Year Est. Return
SC
Serenity Capital Palo Alto, California $167M AUM
MADFP
Michael A Dubis Financial Planning Middleton, Wisconsin $103M AUM
RM
RCF Management Denver, Colorado $103M AUM
NC
Napatree Capital Westerly, Rhode Island $178M AUM 8.09% 1-Year Est. Return
GWA
GGM Wealth Advisors Baltimore, Maryland $180M AUM 10.57% 1-Year Est. Return

RP Management's Q2 2021 Portfolio in Review

As of Q2 2021, RP Management held 5 positions worth $205M, down 23% from $266M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RP Management withdrew a net $102M in Q2 2021, closing 1 position and reducing 1 holding. Its most notable exit was Cytokinetics, an estimated $20.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 92% a quarter earlier, followed by Miscellaneous.

  • RP Management's biggest Q2 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $81.2M.
  • RP Management fully exited Cytokinetics in Q2 2021, selling an estimated $20.4M.
  • RP Management's ten largest holdings make up 100% of its $205M portfolio in Q2 2021.
  • RP Management opened 0 new positions and closed 1 in Q2 2021.
  • RP Management's portfolio value fell 23% quarter-over-quarter to $205M.

Based on RP Management's 13F filing for Q2 2021, filed 12 Aug 2021.